New: NCI-funded clinical trial search
Mednet Logo
CommunityRadiation Oncology

Radiation Oncology

Expert insights on radiation treatment planning, techniques, toxicity management, and multimodal cancer care.

Recent Discussions

How would you approach neoadjuvant chemoradiation in a patient with a history of Crohn’s disease diagnosed with regional lymph node-positive esophageal adenocarcinoma of the GE junction?

1
2 Answers

Mednet Member
Radiation Oncology · Vanderbilt-Ingram Cancer Center

Remember that GEJ was evaluated in MAGIC (and more recently, FLOT4) trial. From FLOT4, about 25% of patients were Siewert I, while another 33% were Siewert II/III.Therefore, if concerns about the severity of Crohn's (and potential RT toxicity) are a significant issue, a reasonable treatment paradigm...

Would you consider RT to LNs in a gr 2-3 adenocarcinoma of the lacrimal gland if there are high risk features?

1 Answers

Mednet MemberInvited Expert
Radiation Oncology · Medical University of South Carolina, Charleston

I always irradiate regional nodes. I treat facial and levels 1 to 3. I have seen failures in facial nodes when only levels 1 to 3 are treated. I have seen level 1 failures when only the facial nodes are treated. These are aggressive cancers. I treat with IMRT.

Would you rather start radiation for Stage III NSCLC in the middle of a chemotherapy cycle or wait for the 2nd cycle if it could not be started on cycle 1 day 1?

4
1 Answers

Mednet Member
Medical Oncology · Hematology-Oncology Associates of Fredericksburg, Inc.

While we all strive to provide streamlined multidisciplinary care, it may not always be possible to start at the same time. I usually discuss this with my collaborating radiation oncology physician. I usually like to time the radiation on D1 for logistical reasons. RT treatments for stage 3 disease ...

About Mednet

A community where doctors find answers to medicine's toughest questions.

  • Verified, credentialed physicians
  • 45,000+ members across 24 specialties
  • Free CME and MOC credit

If you are treating a patient with palliative radiation for hemoptysis do you require chemotherapy to be held?

4 Answers

Mednet MemberInvited Expert
Radiation Oncology · Montefiore Einstein Comprehensive Cancer Center

This is an interesting question. I would like to thank @Dr. First Last for his help with this. In recent years, I have rarely found myself asking colleagues from Medical Oncology to hold chemotherapy for patients who require palliative radiotherapy for hemoptysis. That being said, very few such pati...

How would you approach treatment of a posterior fossa metastasis with surrounding vasogenic edema causing mass effect on the 4th ventricle in an asymptomatic patient?

3 Answers

Mednet MemberInvited Expert
Radiation Oncology · Renaissance Institute of Precision Oncology & Radiosurgery

Agree with Dr Chao's answer above on this. In our institution, our treatment of these lesions (in the context of limited mets and no LMD) falls into 3 categories: -preop SRS, usually 15Gy/1fx to the lesion followed by resection that day, sometimes followed by post-op SRS if lesion still felt to be h...

Is it reasonable to only treat the inguinal nodes and not the pelvic nodes in an unresectable cT1cN0 vulvar SCC at the clitoris?

1
1 Answers

Mednet MemberInvited Expert
Radiation Oncology · Varian Medical Systems/Allegheny health network

If lesion is superficial one can but if thick lesion based on drainage pattern would favor both inguinal region and lower pelvic nodes

How do you manage acute esophagitis that persists > 1-2 months after completing chemoradiation for lung cancer?

2 Answers

Mednet MemberInvited Expert
Radiation Oncology · Quillen VA Medical Center

Harsh protracted esophagitis was reported in 4% of Int. O139(1999)i.e., grade 4 regardless of once or twice daily cycle 1 concurrent. CONVERT reports 18% grade 3!or higher, either QD 66 or BID 45. No reports of > 1 mo duration. Consider endoscopy and culture. Empiric carafate and anti-fungal/candida...